Position in OGN
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$15,571
+$7,613 QoQ
Shares Held
1,150
+3.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#329
of 626 holders
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 50%
Shared 0%
None 50%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TRUST CO OF VERMONT holds $143,988,175 across 14 Drug Manufacturers - General names. OGN ranks #14 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
212,013 | $53,844,941 | |
| 2 | ABBV |
AbbVie Inc.
|
162,450 | $40,878,917 | |
| 3 | MRK |
Merck & Co., Inc.
|
106,435 | $13,676,897 | |
| 4 | LLY |
ELI LILLY & Co
|
8,529 | $10,229,939 | |
| 5 | AMGN |
Amgen Inc
|
22,744 | $8,236,057 | |
| 6 | NVS |
Novartis AG
|
46,466 | $7,282,150 | |
| 7 | PFE |
Pfizer Inc
|
158,728 | $3,822,169 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
49,346 | $2,843,316 |
All Filings in OGN
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,571 | 1,150 | Shares | Sole | 2026-08-07 | |
| 2025-12-31 | $7,958 | 1,110 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $25,204 | 2,360 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $22,554 | 2,330 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $47,171 | 3,168 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $41,209 | 2,762 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $50,235 | 2,626 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $25,957 | 1,254 | Shares | Sole | 2024-07-09 | |
| 2024-03-31 | $24,402 | 1,298 | Shares | Sole | 2024-05-03 | |
| No filing history on record for this holder in this stock. | ||||||